Athanor Capital, LP Allakos Inc. Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$109.73 - $153.66 $213,534 - $299,022	-1,946 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $154,862 - $296,667	1,946 New	1,946 $272,000
Q1 2020 May 14, 2020	SELL	$44.49 - $93.39 $102,327 - $214,797	-2,300 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $135,972 - $281,657	-2,045 Reduced 47.07%	2,300 $219,000
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $134,695 - $389,876	4,345 New	4,345 $342,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.